323 related articles for article (PubMed ID: 31348886)
21. Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.
Saunders KO; Verkoczy LK; Jiang C; Zhang J; Parks R; Chen H; Housman M; Bouton-Verville H; Shen X; Trama AM; Scearce R; Sutherland L; Santra S; Newman A; Eaton A; Xu K; Georgiev IS; Joyce MG; Tomaras GD; Bonsignori M; Reed SG; Salazar A; Mascola JR; Moody MA; Cain DW; Centlivre M; Zurawski S; Zurawski G; Erickson HP; Kwong PD; Alam SM; Levy Y; Montefiori DC; Haynes BF
Cell Rep; 2017 Dec; 21(13):3681-3690. PubMed ID: 29281818
[TBL] [Abstract][Full Text] [Related]
22. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
[TBL] [Abstract][Full Text] [Related]
23. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.
Gao F; Bonsignori M; Liao HX; Kumar A; Xia SM; Lu X; Cai F; Hwang KK; Song H; Zhou T; Lynch RM; Alam SM; Moody MA; Ferrari G; Berrong M; Kelsoe G; Shaw GM; Hahn BH; Montefiori DC; Kamanga G; Cohen MS; Hraber P; Kwong PD; Korber BT; Mascola JR; Kepler TB; Haynes BF
Cell; 2014 Jul; 158(3):481-91. PubMed ID: 25065977
[TBL] [Abstract][Full Text] [Related]
24. HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies.
McGuire AT; Dreyer AM; Carbonetti S; Lippy A; Glenn J; Scheid JF; Mouquet H; Stamatatos L
Science; 2014 Dec; 346(6215):1380-1383. PubMed ID: 25504724
[TBL] [Abstract][Full Text] [Related]
25. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
J Virol; 2017 May; 91(9):. PubMed ID: 28202751
[TBL] [Abstract][Full Text] [Related]
26. Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine.
Zhou T; Xu K
Adv Exp Med Biol; 2018; 1075():73-95. PubMed ID: 30030790
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.
von Bredow B; Arias JF; Heyer LN; Moldt B; Le K; Robinson JE; Zolla-Pazner S; Burton DR; Evans DT
J Virol; 2016 Jul; 90(13):6127-6139. PubMed ID: 27122574
[TBL] [Abstract][Full Text] [Related]
28. Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.
Cai F; Chen WH; Wu W; Jones JA; Choe M; Gohain N; Shen X; LaBranche C; Eaton A; Sutherland L; Lee EM; Hernandez GE; Wu NR; Scearce R; Seaman MS; Moody MA; Santra S; Wiehe K; Tomaras GD; Wagh K; Korber B; Bonsignori M; Montefiori DC; Haynes BF; de Val N; Joyce MG; Saunders KO
PLoS Pathog; 2021 Jun; 17(6):e1009624. PubMed ID: 34086838
[TBL] [Abstract][Full Text] [Related]
29. Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site.
Bradley T; Fera D; Bhiman J; Eslamizar L; Lu X; Anasti K; Zhang R; Sutherland LL; Scearce RM; Bowman CM; Stolarchuk C; Lloyd KE; Parks R; Eaton A; Foulger A; Nie X; Karim SSA; Barnett S; Kelsoe G; Kepler TB; Alam SM; Montefiori DC; Moody MA; Liao HX; Morris L; Santra S; Harrison SC; Haynes BF
Cell Rep; 2016 Jan; 14(1):43-54. PubMed ID: 26725118
[TBL] [Abstract][Full Text] [Related]
30. Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.
Burton S; Spicer LM; Charles TP; Gangadhara S; Reddy PBJ; Styles TM; Velu V; Kasturi SP; Legere T; Hunter E; Pulendran B; Amara R; Hraber P; Derdeyn CA
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651354
[TBL] [Abstract][Full Text] [Related]
31. An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes.
Chen Y; Wilson R; O'Dell S; Guenaga J; Feng Y; Tran K; Chiang CI; Arendt HE; DeStefano J; Mascola JR; Wyatt RT; Li Y
J Immunol; 2016 Nov; 197(10):3982-3998. PubMed ID: 27815444
[TBL] [Abstract][Full Text] [Related]
32. Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response.
Dubrovskaya V; Guenaga J; de Val N; Wilson R; Feng Y; Movsesyan A; Karlsson Hedestam GB; Ward AB; Wyatt RT
PLoS Pathog; 2017 Sep; 13(9):e1006614. PubMed ID: 28902916
[TBL] [Abstract][Full Text] [Related]
33. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
[TBL] [Abstract][Full Text] [Related]
34. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.
Voss JE; Andrabi R; McCoy LE; de Val N; Fuller RP; Messmer T; Su CY; Sok D; Khan SN; Garces F; Pritchard LK; Wyatt RT; Ward AB; Crispin M; Wilson IA; Burton DR
Cell Rep; 2017 Oct; 21(1):222-235. PubMed ID: 28978475
[TBL] [Abstract][Full Text] [Related]
35. Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
Williams WB; Alam SM; Ofek G; Erdmann N; Montefiori DC; Seaman MS; Wagh K; Korber B; Edwards RJ; Mansouri K; Eaton A; Cain DW; Martin M; Hwang J; Arus-Altuz A; Lu X; Cai F; Jamieson N; Parks R; Barr M; Foulger A; Anasti K; Patel P; Sammour S; Parsons RJ; Huang X; Lindenberger J; Fetics S; Janowska K; Niyongabo A; Janus BM; Astavans A; Fox CB; Mohanty I; Evangelous T; Chen Y; Berry M; Kirshner H; Van Itallie E; Saunders KO; Wiehe K; Cohen KW; McElrath MJ; Corey L; Acharya P; Walsh SR; Baden LR; Haynes BF
Cell; 2024 Jun; 187(12):2919-2934.e20. PubMed ID: 38761800
[TBL] [Abstract][Full Text] [Related]
36. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
Hessell AJ; Malherbe DC; Pissani F; McBurney S; Krebs SJ; Gomes M; Pandey S; Sutton WF; Burwitz BJ; Gray M; Robins H; Park BS; Sacha JB; LaBranche CC; Fuller DH; Montefiori DC; Stamatatos L; Sather DN; Haigwood NL
J Immunol; 2016 Apr; 196(7):3064-78. PubMed ID: 26944928
[TBL] [Abstract][Full Text] [Related]
37. Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
van Diepen MT; Chapman R; Douglass N; Galant S; Moore PL; Margolin E; Ximba P; Morris L; Rybicki EP; Williamson AL
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760570
[TBL] [Abstract][Full Text] [Related]
38. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.
Cale EM; Gorman J; Radakovich NA; Crooks ET; Osawa K; Tong T; Li J; Nagarajan R; Ozorowski G; Ambrozak DR; Asokan M; Bailer RT; Bennici AK; Chen X; Doria-Rose NA; Druz A; Feng Y; Joyce MG; Louder MK; O'Dell S; Oliver C; Pancera M; Connors M; Hope TJ; Kepler TB; Wyatt RT; Ward AB; Georgiev IS; Kwong PD; Mascola JR; Binley JM
Immunity; 2017 May; 46(5):777-791.e10. PubMed ID: 28514685
[TBL] [Abstract][Full Text] [Related]
39. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation.
Dai K; Khan SN; Wang Y; He L; Guenaga J; Ingale J; Sundling C; O'Dell S; McKee K; Phad G; Corcoran M; Wilson R; Mascola JR; Zhu J; Li Y; Karlsson Hedestam GB; Wyatt RT
Sci Rep; 2016 Feb; 6():20987. PubMed ID: 26879974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
